In this file
Getting help from Hims starts with identifying the kind of question you have. A login issue, a missing shipment, a prescription concern, and a renewal charge may need different people.
Use the official contact routes below rather than a phone number added to a search result by an unknown directory. We link to provider information and explain its limits; Is X Legitimate does not operate the provider’s support service.
Published ways to get in touch
The published telephone number for Hims is (800) 368-0038.
The published contact details identify a way to reach the business. They do not guarantee a response time or establish that a prescribing professional answers the telephone. Ask the representative to direct the request to the appropriate team.
Account and patient-portal access
Start from the official Hims website and follow its patient sign-in or help link. We did not establish a separate stable login address for this file.
If a password does not work, use the reset process from that verified site. Do not send a password, access code, full payment-card number, or medical record to this publication or to an unsolicited person offering to resolve the account.
For a payment or cancellation request
The August 31 terms say the first membership month is non-refundable and shipped medication is not refundable. Other medication cancellation and refund circumstances have their own timing rules. Read the membership clause and medication clause independently, then ask which applies to the pending charge.
Include the date and amount of the charge, the order or membership reference, and the specific action requested. Ask whether stopping Hims membership also stops any pending prescription. Keep the written response with the cancellation guidance.
For a medicine or shipment question
The strategic announcement is neither proof that compounding disappeared completely nor a promise that it is available on request. The treating professional should name the actual medicine and explain the medical reason for any proposed compounded preparation.
Ask the pharmacy about preparation, labeling, storage, and the medicine it dispensed. Ask the treating clinician about suitability, side effects, or a change in instructions. A carrier tracking page can show parcel movement but cannot answer whether a medication remains suitable after a storage problem.
If you have not joined yet
Is this quote for membership, medication, or both, and what product would a current clinician actually consider?
The current documents distinguish Weight Loss Membership from a Medication Plan. We did not establish one current combined price for every product and pathway. Quotes copied from an older compounded-semaglutide campaign may not describe enrollment today.
Use the Hims provider file to put the support answer beside the medical and payment arrangements. A helpful sales conversation is useful, but it is not a completed assessment or a prescription.
When ordinary support is not enough
Do not wait for a routine support reply if you think you are having a medical emergency. For severe symptoms or an immediate threat to safety, seek urgent local help. For non-emergency medication concerns, contact your treating professional rather than improvising a change while waiting.
The medication side-effect guide explains how routine administrative contact differs from clinical and urgent care.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- Hims & Hers: March 9, 2026 weight-loss strategy announcement ↗Provider-published information · Checked September 22, 2026
- Hims: terms updated August 31, 2026 ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- MedlinePlus: semaglutide injection ↗Medical reference · Checked September 22, 2026
- MedlinePlus: tirzepatide injection ↗Medical reference · Checked September 22, 2026